Confinia Cephalalgica

Aims & Scope

La rivista pubblica con periodicità quadrimestrale contributi teorici sperimentali di ricerche biomediche e in scienze umane a carattere multidisciplinare prioritariamente dedicati allo studio, diagnosi e cura delle cefalee e altri MAL DI TESTA nell’accezione più vasta di sindromi e manifestazioni dolorose complesse ai confini tra natura e cultura, tra mente e cervello, archetipi, comportamenti e stile di vita.

Il nuovo piano editoriale della rivista rispecchia, nella sua architettura, un’idea di “forum circolo”, “palestra costellazione” di ricerche e contributi che, a partire dal nucleo centrale delle cefalee e disturbi adattativi correlati, si sviluppa in cerchi di riflessione e approfondimenti sempre più ampi, che comprendono editoriali di interesse, saggi monografici, interviste con protagonisti della ricerca in neuroscienze, lavori originali e sezioni dedicate quali: neurofisiologia, neuroteoretica, scienze cognitive, neurogenetica, cybermedicina, arte emicranica, storia della medicina, sport e società, letteratura, medicina popolare.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.113

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	5

Journal Rank

Year	Value
2024	28096

Journal Citation Indicator

Year	Value
2024	11

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Prospective evaluation of aura during anti-calcitonin gene-related peptide monoclonal antibody therapy after 52 weeks of treatment

  Citation: 6

  Authors: Marina, Andrea, Catello, Maria, Giulia, Francesco, Alberto, Paolo, Luigi Francesco

• Manual trigger point treatment in migraine management: a scope review

  Citation: 2

  Authors: Roberto

• Sex and gender differences in the epidemiology, clinical features, and pathophysiology of trigeminal autonomic cephalalgias

  Citation: 2

  Authors: Selene, Andrea, Giulia, Francesco, Marina, Luigi Francesco

• ID-Migraine test for pediatric population: preliminary results from the Italian validation

  Citation: 1

  Authors: Ilaria, Laura, Fabiana, Giorgia, Gabriele, Luigi, Massimiliano

• Aromatase inhibitors evoke periorbital allodynia in mice via calcitonin gene-related peptide and its receptors in Schwann cells

  Citation: 0

  Authors: Matilde, Daniel, Martina, Elisa, Gaetano, Alessandra, Irene, Martina, Pasquale, Romina, Francesco, Lorenzo

• Cortical excitability in patients with migraine with aura and depressive symptoms: a visual evoked potentials study

  Citation: 0

  Authors: Francesco, Chiara, Gabriele, Antonio, Vincenzo, Ettore, Mariano, Cherubino

• Kinetic oscillation stimulation for the preventive treatment of refractory chronic migraine: a case series

  Citation: 0

  Authors: Giorgio, Claudia, Nicoletta, Alessandro, Luisa, Maria Pia, Fabrizio

• Persistent idiopathic facial pain, a challenging diagnostic entity: clinical series from a third-level headache center

  Citation: 0

  Authors: Danilo Antonio, Alberto, Marina, Licia

• Migraine management in adolescents: treatment requires a multimodal approach

  Citation: 0

  Authors: Licia, Paul B., Danilo Antonio, Alberto

• Normative values of the nociceptive blink reflex habituation

  Citation: 0

  Authors: Michele, Elena, Gloria, Francescantonio, Federico, Alessandro, Daniele, Maria Magdalena, Luca, Valentina, Sara, Armando, Giuseppe, Grazia, Cristina, Roberto

---